These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23015643)
1. Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury. Wang QM; Stalker TJ; Gong Y; Rikitake Y; Scalia R; Liao JK Vasc Med; 2012 Dec; 17(6):379-85. PubMed ID: 23015643 [TBL] [Abstract][Full Text] [Related]
2. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783 [TBL] [Abstract][Full Text] [Related]
3. ρ-Kinase inhibition reduces early microvascular leukocyte accumulation in the rat kidney following ischemia-reperfusion injury: roles of nitric oxide and blood flow. Versteilen AM; Blaauw N; Di Maggio F; Groeneveld AB; Sipkema P; Musters RJ; Tangelder GJ Nephron Exp Nephrol; 2011; 118(4):e79-86. PubMed ID: 21311198 [TBL] [Abstract][Full Text] [Related]
4. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase. McGown CC; Brown NJ; Hellewell PG; Brookes ZL Microvasc Res; 2011 May; 81(3):281-8. PubMed ID: 21354186 [TBL] [Abstract][Full Text] [Related]
5. Ischemic preconditioning attenuates postischemic leukocyte--endothelial cell interactions: role of nitric oxide and protein kinase C. Huang SS; Wei FC; Hung LM Circ J; 2006 Aug; 70(8):1070-5. PubMed ID: 16864944 [TBL] [Abstract][Full Text] [Related]
6. Rho-kinase signalling regulates CXC chemokine formation and leukocyte recruitment in colonic ischemia-reperfusion. Santen S; Wang Y; Laschke MW; Menger MD; Jeppsson B; Thorlacius H Int J Colorectal Dis; 2010 Sep; 25(9):1063-70. PubMed ID: 20593289 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Rho kinase by fasudil hydrochloride attenuates lung injury induced by intestinal ischemia and reperfusion. Li Y; Yao JH; Hu XW; Fan Z; Huang L; Jing HR; Liu KX; Tian XF Life Sci; 2011 Jan; 88(1-2):104-9. PubMed ID: 21056587 [TBL] [Abstract][Full Text] [Related]
8. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo. Slotta JE; Braun OO; Menger MD; Thorlacius H Inflamm Res; 2006 Sep; 55(9):364-7. PubMed ID: 17122957 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioninng in hypercholesterolemic rat heart. Wu N; Li W; Shu W; Lv Y; Jia D Mol Med Rep; 2014 Nov; 10(5):2517-24. PubMed ID: 25231456 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway. Sugimoto M; Yamanouchi D; Komori K Surg Today; 2009; 39(6):459-65. PubMed ID: 19468800 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo use of a Rho-kinase inhibitor during renal preservation improves graft function upon reperfusion. Kirchner C; Lüer B; Efferz P; Wohlschlaeger J; Paul A; Minor T Cryobiology; 2015 Feb; 70(1):71-5. PubMed ID: 25555715 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide. Scalia R; Booth G; Lefer DJ FASEB J; 1999 Jun; 13(9):1039-46. PubMed ID: 10336886 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice. Priviero FB; Jin LM; Ying Z; Teixeira CE; Webb RC J Pharmacol Exp Ther; 2010 Apr; 333(1):184-92. PubMed ID: 20093396 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes. Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205 [TBL] [Abstract][Full Text] [Related]
17. Fasudil, a Rho-associated protein kinase inhibitor, attenuates retinal ischemia and reperfusion injury in rats. Song H; Gao D Int J Mol Med; 2011 Aug; 28(2):193-8. PubMed ID: 21455561 [TBL] [Abstract][Full Text] [Related]
18. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Hamid SA; Bower HS; Baxter GF Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176 [TBL] [Abstract][Full Text] [Related]
19. Rho-kinase activation in leukocytes plays a pivotal role in myocardial ischemia/reperfusion injury. Kitano K; Usui S; Ootsuji H; Takashima S; Kobayashi D; Murai H; Furusho H; Nomura A; Kaneko S; Takamura M PLoS One; 2014; 9(3):e92242. PubMed ID: 24638037 [TBL] [Abstract][Full Text] [Related]